BAM
RETA

Blueshift Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Blueshift Asset Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,007
Closed -$409K – 456
2023
Q2 		$409K Buy
+4,007
New +$409K 0.16% 161
2021
Q2 		– Sell
-2,991
Closed -$298K – 1238
2021
Q1 		$298K Buy
+2,991
New +$298K 0.03% 641